PHAT Q3 2022 Earnings — Phathom Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PHATPhathom Pharmaceuticals, Inc.

$891M

Q3 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$175,000

Operating Income

-$43M

Net Income

-$51M

EPS (Diluted)

$-1.54

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$202M

Total Liabilities

$228M

Stockholders' Equity

-$26M

Cash & Equivalents

$197M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$175,000	-$130,000	-34.6%
Operating Income	-$43M	-$33M	-28.3%
Net Income	-$51M	-$37M	-39.4%